研究关注：STAT+: Pharmalittle: We’re reading about an FDA gender rule change, its program for one-day inspections, and more

## 事件概览

An FDA proposal to remove references to “gender” from its regulations sparked concerns about unintended consequences on research

## 核心信息

An FDA proposal to remove references to “gender” from its regulations sparked concerns about unintended consequences on research

## 为什么值得关注

这条内容与 生命科学 相关，可能影响科研选题、技术趋势判断或产业观察。BioDir 已根据来源、摘要长度、主题词和潜在影响给出 20 分的候选评分。

## 发布提示

发布前应核对原文链接、研究对象、样本规模、方法限制和结论边界。若来源为 bioRxiv 或 medRxiv，应明确标注其为预印本，尚未经过同行评议。